Watch the Discussion on Endoscopic Therapy in Barrett's Esophagus
Roundtable 4. Episode 3.
Barrett’s Esophagus is associated with long-term gastro-esophageal reflux disease (GERD) and is a risk factor for esophageal cancer. Current practice is to screen select patients who have multiple risk factors for esophageal cancer and monitor those patients diagnosed with Barrett's esophagus for development of precancerous change (dysplasia). Patients who are at higher risk of progressing to esophageal cancer may benefit from endoscopic therapy.
An expert roundtable discussion on the management of Barrett’s Esophagus was recorded in three episodes during the 16th World Congress for Esophageal Diseases in Vienna, Austria. In Episode 3 our panelists discuss who should be treated, tools and skills required in endoscopic therapy, alternative therapies, the role of RFA, challenges, techniques and practices, other modalities and surveillance after treatment.
Thanks to our international panelists:
- Vani Konda, Baylor University Medical Center, USA
- Gary Falk, University of Pennsylvania Perelman School of Medicine Philadelphia, USA
- Prateek Sharma, University of Kansas School of Medicine and VA Medical Center, USA
- Peter Siersema, Radboud University Medical Center, Netherlands
- Kenneth Wang, Mayo Clinic Rochester, USA
Visit isde.net/barrett-esophagus for more information, resources and earlier episodes.